Clinical trial
Topical Amitriptyline 1% Gel for the Treatment of Burning Mouth Syndrome
NCT07214181 is registered in ClinicalTrials.gov with Universidad de Murcia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Topical Amitriptyline 1% Gel for the Treatment of Burning Mouth Syndrome
- Lead sponsor
- Universidad de Murcia
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 2, 2024
- Completion date
- May 30, 2025
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
burning mouth syndrome, stomatodynia